Essex Woodlands Health Ventures

Essex Woodlands Health Ventures as of Sept. 30, 2017

Portfolio Holdings for Essex Woodlands Health Ventures

Essex Woodlands Health Ventures holds 9 positions in its portfolio as reported in the September 2017 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Abiomed 28.3 $160M 947k 168.60
Revance Therapeutics (RVNC) 22.4 $127M 4.6M 27.55
Corium Intl 18.4 $104M 9.4M 11.08
Axogen (AXGN) 16.7 $94M 4.9M 19.35
Entellus Medical Cm 10.6 $60M 3.2M 18.46
Endologix 2.0 $11M 1.3M 9.08
MediciNova (MNOV) 1.3 $7.5M 1.2M 6.37
Acura Pharmaceuticals (ACUR) 0.2 $880k 2.0M 0.45
Catalyst Biosciences 0.1 $404k 79k 5.14